Fatal spontaneous intraperitoneal hemorrhage in association with apixaban: A case report-Reference-Cited by-同舟云学术

Fatal spontaneous intraperitoneal hemorrhage in association with apixaban: A case report

Published:2024-06-19 Issue:1 Volume:15 Page:99-102
ISSN:0976-3198
Container-title:International Journal of Case Reports and Images
language:en
Short-container-title:Int J Case Rep Images

Author:

P Mckenna Daniel¹,Kelly Martin²,Murphy Terence³

Affiliation:

1. MRCS, SHO, Department of Trauma and Orthopaedic Surgery, University Hospital Waterford, Dunmore Road, Waterford X91 ER8E, Ireland

2. FRCS, SpR, Department of Trauma and Orthopaedic Surgery, University Hospital Waterford, Dunmore Road, Waterford X91 ER8E, Ireland

3. FRCS, Consultant, Department of Trauma and Orthopaedic Surgery, University Hospital Waterford, Dunmore Road, Waterford X91 ER8E, Ireland

Abstract

We present the case of an 80-year-old gentleman with a spontaneous intraperitoneal hemorrhage secondary to direct oral anticoagulant (DOAC) medication. As far as we are aware this is the third documented case of spontaneous intraperitoneal hemorrhage in association with direct oral anticoagulants (DOACs) therapy. Previously published cases have also cited apixaban as the associated DOAC. With their increasing prevalence, spontaneous intraperitoneal hemorrhage should be a recognized presentation for the patient in extremis on DOAC therapy.

Publisher

Edorium Journals Pvt. Ltd.

Reference10 articles.

1. Cawyer JC, Stone CK. Abdominal apoplexy: A case report and review. J Emerg Med 2011;40(3):e49–52.

2. Ballesta M, Piqueras R, Brugger S, Estellés Lerga P. Non-traumatic spontaneous abdominal haemorrhage. Radiologia (Engl Ed) 2023;65 Suppl 1:S73–80.

3. Law EK, Lee RK, Hung EHY, Ng AW. Radiological diagnosis and management of idiopathic spontaneous intra-abdominal haemorrhage (abdominal apoplexy): A case series. Abdom Imaging 2015;40(2):343–51.

4. Steffel J, Collins R, Antz M, et al. 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace 2021;23(10):1612–76.

5. Jackevicius CA, Lu L, Ghaznavi Z, Warner AL. Bleeding risk of direct oral anticoagulants in patients with heart failure and atrial fibrillation. Circ Cardiovasc Qual Outcomes 2021;14(2):e007230.